Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
about
Body fluid biomarkers in Alzheimer's diseaseYKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies.Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery diseaseThe Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2.Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease.YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades.Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.Deciphering the Astrocyte Reaction in Alzheimer's Disease.Novel CSF biomarkers to discriminate FTLD and its pathological subtypesElevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor PrognosisYKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
P2860
Q26830098-A7A60581-A6C0-499A-8394-F0C9ABCF3BFEQ33784904-36AA61B4-4ACB-4149-B359-2EE940618208Q34834538-DA5D8120-544E-4304-86DE-811C8381CE6DQ35745168-7D3355C9-ECAF-4D30-916B-B0264E3F86FDQ36071742-EC359B5F-9F63-49D4-B78E-9E91AC9B554AQ36189198-E1C5B2BA-D290-4FB5-89F9-A0F6C99A9FF5Q36265825-6F2EA52A-2E21-4C87-B25D-F8611D01DA68Q36266994-A722BB4F-2353-4E8D-8C86-2F6F66D92994Q36353787-FC820572-1E7F-47A8-8A87-0FAD03DEEE4AQ36402008-E17E64F5-500E-422B-A84A-82E745748E8EQ36439886-792E28A4-BE4D-4142-888B-1D4DF5934C48Q36599172-22817A1D-2A94-4B01-9177-EBFF2262C85BQ37565386-AEBC05CC-A23B-40D5-B1C9-E63578139F78Q37648226-25BBFAB2-2A87-4BCF-89F8-981EA9E80C2DQ38430889-DBBB229D-3453-4C06-A5AE-854D66C77C64Q38759253-1D1742D0-C5B8-44C0-9D96-0B1AF56EDE11Q45811351-21FA31E1-CEFD-490C-AFC0-AECBFC970E7CQ52644606-AAE3AE32-9BC1-4267-A234-14AB4EC7C588Q53430039-40047B1E-FCDB-4C68-9E42-44F34B851F86Q55364689-74022052-936A-4628-8961-AF5221DA84CDQ57822410-CB09EB09-642A-4FC9-92E2-DE0EA51C3148Q58122618-6976CDDB-5A4D-4D9D-A203-09C8CE5F0086Q58742056-D4B1C8BB-4EE7-40BC-A502-93C2763F4C1B
P2860
Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Cerebrospinal fluid level of Y ...... prodromal Alzheimer's disease.
@en
Cerebrospinal fluid level of Y ...... prodromal Alzheimer's disease.
@nl
type
label
Cerebrospinal fluid level of Y ...... prodromal Alzheimer's disease.
@en
Cerebrospinal fluid level of Y ...... prodromal Alzheimer's disease.
@nl
prefLabel
Cerebrospinal fluid level of Y ...... prodromal Alzheimer's disease.
@en
Cerebrospinal fluid level of Y ...... prodromal Alzheimer's disease.
@nl
P2093
P356
P1476
Cerebrospinal fluid level of Y ...... prodromal Alzheimer's disease.
@en
P2093
Albert Lladó
Alex Iranzo
Alicia Mansilla
Anna Antonell
Jaume Olives
Lorena Rami
Raquel Sánchez-Valle
P304
P356
10.3233/JAD-140624
P577
2014-01-01T00:00:00Z